| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-01-17 | Lim Kok Thay 10% Owner | Purchase | +43,263,729 | +143.91%73,326,508 | $0.19 | $8,062,928 | View SEC filing | |
| 2023-10-10 | Hariri Robert J Chief Executive Officer | Purchase | +18,422,124 | +181.53%28,570,434 | $0.16 | $2,984,294 | View SEC filing | |
| 2023-10-05 | Sorrento Therapeutics, Inc. 10% Owner | Sale | -15,371,697 | -75.27%5,050,427 | N/A | N/A | View SEC filing | |
| 2023-06-22 | Genting Berhad 10% Owner | Purchase | +3,000,000 | +100.00%3,000,000 | $0.13 | $375,000 | View SEC filing | |
| 2022-11-30 | Hariri Robert J Chief Executive Officer | Purchase | +10,000 | +0.12%8,074,996 | $1.72 | $17,175 | View SEC filing | |
| 2022-11-29 | Hariri Robert J Chief Executive Officer | Purchase | +40,000 | +0.50%8,064,996 | $1.71 | $68,400 | View SEC filing | |
| 2022-11-28 | Hariri Robert J Chief Executive Officer | Purchase | +40,000 | +0.50%8,024,996 | $1.74 | $69,600 | View SEC filing |
1-7 of 7
